Madison Avenue

SL Green Signs Leases Totaling 104,000 Square Feet at One Madison Avenue

Retrieved on: 
Tuesday, April 9, 2024
Madison Avenue, SL Green Realty, Coffee, David Rockwell, Travel, Flutter Entertainment, Food, JLL, Seafood, Daniel, Real property, SLG, Tree, Nightclub

NEW YORK, April 09, 2024 (GLOBE NEWSWIRE) -- SL Green Realty Corp. (NYSE: SLG), Manhattan’s largest office landlord, today announced three new tenants have signed leases covering 104,110 square feet at One Madison Avenue.

Key Points: 
  • NEW YORK, April 09, 2024 (GLOBE NEWSWIRE) -- SL Green Realty Corp. (NYSE: SLG), Manhattan’s largest office landlord, today announced three new tenants have signed leases covering 104,110 square feet at One Madison Avenue.
  • Italian specialty sandwich shop ALIDORO signed a new 1,004-square-foot, 12-year lease on a portion of the ground floor.
  • “We’re excited to welcome these new tenants to One Madison Avenue which is Midtown South’s most exciting new office development,” said Steven Durels, Executive Vice President, Director of Leasing and Real Property at SL Green.
  • The design was inspired by the green oasis and vibrant urban hub that is Madison Square Park.

Zhibao Technology Inc. Announces Closing of Initial Public Offering

Retrieved on: 
Wednesday, April 3, 2024
Fintech, Madison Avenue, EF Hutton, Offering, Form, Telephone, Sale, Attention, Prospectus, File, Security (finance)

Shanghai, China, April 03, 2024 (GLOBE NEWSWIRE) -- Zhibao Technology Inc. (Nasdaq: “ZBAO” or the “Company”), a leading and high growth InsurTech company primarily engaging in providing digital insurance brokerage services through its operating entities in China, today announced the closing of its initial public offering ("Offering”) of 1,500,000 Class A ordinary shares at a public offering price of $4.00 per Class A ordinary share for aggregate gross proceeds of $6,000,000, before deducting underwriting discounts and offering expenses.

Key Points: 
  • Shanghai, China, April 03, 2024 (GLOBE NEWSWIRE) -- Zhibao Technology Inc. (Nasdaq: “ZBAO” or the “Company”), a leading and high growth InsurTech company primarily engaging in providing digital insurance brokerage services through its operating entities in China, today announced the closing of its initial public offering ("Offering”) of 1,500,000 Class A ordinary shares at a public offering price of $4.00 per Class A ordinary share for aggregate gross proceeds of $6,000,000, before deducting underwriting discounts and offering expenses.
  • The Company has granted the underwriters a 45-day option to purchase up to an additional 225,000 Class A ordinary shares to cover the over-allotment at the public offering price, less underwriting discounts and commissions.
  • The Class A ordinary shares began trading on the Nasdaq Capital Market on April 2, 2024 under the symbol "ZBAO."
  • In addition, a copy of the final prospectus relating to the Offering may be obtained via the SEC's website at www.sec.gov .

Matinas BioPharma Prices $10 Million Registered Direct Offering

Retrieved on: 
Wednesday, April 3, 2024
Form, Prospectus, LNC, File, Sale, Madison Avenue, S-3, Security (finance)

The gross proceeds of the offering will be approximately $10 million before deducting fees and other estimated offering expenses.

Key Points: 
  • The gross proceeds of the offering will be approximately $10 million before deducting fees and other estimated offering expenses.
  • The closing of the offering is expected to take place on or about April 5, 2024, subject to the satisfaction of customary closing conditions.
  • The Company intends to use the net proceeds from the offering for working capital and general corporate purposes.
  • A final prospectus supplement and accompanying base prospectus relating to the offering will be filed by Matinas BioPharma with the SEC.

Zhibao Technology Inc. Announces Pricing of Initial Public Offering

Retrieved on: 
Tuesday, April 2, 2024
Fintech, Madison Avenue, EF Hutton, Offering, Form, Telephone, Sale, Attention, Security (finance), Prospectus, File

The offering is expected to close on April 3, 2024, subject to customary closing conditions.

Key Points: 
  • The offering is expected to close on April 3, 2024, subject to customary closing conditions.
  • EF Hutton LLC is acting as the sole book-running manager for the Offering.
  • The Offering is being made only by means of a prospectus, forming part of the effective registration statement.
  • In addition, a copy of the final prospectus, when available, relating to the Offering may be obtained via the SEC's website at www.sec.gov .

U-BX Technology Ltd. Announces Closing of $10 Million Initial Public Offering

Retrieved on: 
Monday, April 1, 2024
EF Hutton, Common stock, Madison Avenue, Offering, Form, Telephone, Winston & Strawn, Sale, Insurance, Prospectus, ATTN:, Security (finance)

Beijing, April 01, 2024 (GLOBE NEWSWIRE) -- U-BX Technology Ltd. (the “Company” or “UBXG”), an artificial intelligence-driven value-added services and products provider to insurance carriers, today announced the closing of its initial public offering (the "Offering") of 2,000,000 ordinary shares (the "Ordinary Shares") at an initial public offering price of $5.00 per share for total gross proceeds of $10,000,000, before deducting underwriting discounts and other offering expenses.

Key Points: 
  • Beijing, April 01, 2024 (GLOBE NEWSWIRE) -- U-BX Technology Ltd. (the “Company” or “UBXG”), an artificial intelligence-driven value-added services and products provider to insurance carriers, today announced the closing of its initial public offering (the "Offering") of 2,000,000 ordinary shares (the "Ordinary Shares") at an initial public offering price of $5.00 per share for total gross proceeds of $10,000,000, before deducting underwriting discounts and other offering expenses.
  • The Offering closed on April 1, 2024, and the Ordinary Shares began trading on Nasdaq Capital Market on March 28, 2024, under the ticker symbol "UBXG".
  • The Company has granted EF Hutton LLC (“EF Hutton”), the underwriter, an option to purchase up to an additional 300,000 Ordinary Shares at the public offering price, less underwriting discounts, to cover the over-allotments, if any, exercisable within 45 days from the closing date of the Offering.
  • EF Hutton acted as the sole bookrunner for the Offering.

Tonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Direct Offering

Retrieved on: 
Thursday, March 28, 2024
Failure, Madison Avenue, Exercise, Fibromyalgia, Infection, Cocaine, Autoimmunity, Central nervous system, Form, Telephone, Patient, CNS, Research, Sale, NDA, Disease, Cancer, Long, Security (finance), Breakthrough therapy, Nature, Risk, Annual report, Therapy, Series, CD40L, FDA, Sumatriptan, Government, Food

The closing of the offering is expected to take place on or about April 1, 2024, subject to the satisfaction of customary closing conditions.

Key Points: 
  • The closing of the offering is expected to take place on or about April 1, 2024, subject to the satisfaction of customary closing conditions.
  • The gross proceeds of the offering will be approximately $4.4 million before deducting placement agent fees and other estimated offering expenses payable by the Company.
  • A.G.P./Alliance Global Partners is acting as sole placement agent for the offering.
  • This offering is being made pursuant to an effective shelf registration statement on Form S-3 (File No.

Praxis Precision Medicines, Inc. Announces Pricing of $200 Million Public Offering

Retrieved on: 
Thursday, March 28, 2024
Floor, Needham & Company, Madison Avenue, Central nervous system, Form, Telephone, CNS, Truist, Sale, Attention, Security (finance), Guggenheim Partners, Form S-3, Praxis, Nicollet Mall

The gross proceeds from the offering are expected to be approximately $200 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by Praxis.

Key Points: 
  • The gross proceeds from the offering are expected to be approximately $200 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by Praxis.
  • All shares and pre-funded warrants in the offering are being offered by Praxis.
  • In addition, Praxis has granted the underwriters a 30-day option to purchase up to 530,973 additional shares of common stock at the public offering price, less underwriting discounts and commissions.
  • The offering is expected to close on or about April 2, 2024, subject to market conditions and the satisfaction of customary closing conditions.

U-BX Technology Ltd. Announces Pricing of $10Million Initial Public Offering

Retrieved on: 
Wednesday, March 27, 2024
Public, EF Hutton, Madison Avenue, Offering, Form, Telephone, Winston & Strawn, Sale, Insurance, Prospectus, ATTN:, Security (finance)

BEIJING, March 27, 2024 (GLOBE NEWSWIRE) -- U-BX Technology Ltd. (the “Company” or “UBXG”), an artificial intelligence-driven value-added services and products provider to insurance carriers, today announced the pricing of its initial public offering (the "Offering") of 2,000,000 ordinary shares (the "Ordinary Shares") at a public offering price of $5.00 per share (“Public Offering Price”) for total gross proceeds of $10,000,000, before deducting underwriting discounts and other offering expenses.

Key Points: 
  • BEIJING, March 27, 2024 (GLOBE NEWSWIRE) -- U-BX Technology Ltd. (the “Company” or “UBXG”), an artificial intelligence-driven value-added services and products provider to insurance carriers, today announced the pricing of its initial public offering (the "Offering") of 2,000,000 ordinary shares (the "Ordinary Shares") at a public offering price of $5.00 per share (“Public Offering Price”) for total gross proceeds of $10,000,000, before deducting underwriting discounts and other offering expenses.
  • The Offering is being conducted on a firm commitment basis.
  • The Offering is expected to close on or about April 1, 2024, subject to the satisfaction of customary closing conditions.
  • EF Hutton is acting as the sole bookrunner for the Offering.

Praxis Precision Medicines, Inc. Announces Proposed Public Offering

Retrieved on: 
Wednesday, March 27, 2024
Floor, Needham & Company, Madison Avenue, Central nervous system, Form, Telephone, CNS, Truist, Sale, Attention, Security (finance), Guggenheim Partners, Form S-3, Praxis, Nicollet Mall

All securities in the offering will be offered by Praxis.

Key Points: 
  • All securities in the offering will be offered by Praxis.
  • Piper Sandler, Guggenheim Securities and Truist Securities are acting as joint book-running managers for the offering.
  • The offering is subject to market and other customary closing conditions, and there can be no assurance as to whether or when the offering may be completed.
  • The proposed offering will be made only by means of a preliminary prospectus supplement and the accompanying base prospectus.

AppTech Payments Corp. Announces Closing of $2.0 Million Underwritten Public Offering of Common Stock

Retrieved on: 
Wednesday, March 27, 2024
Madison Avenue, EF Hutton, Form, Telephone, Sale, Prospectus, Cryptocurrency

CARLSBAD, Calif., March 27, 2024 (GLOBE NEWSWIRE) -- AppTech Payments Corp. (Nasdaq: APCX) (“AppTech” or the “Company”), a pioneering fintech company powering frictionless commerce, today announced the closing of its previously announced underwritten public offering of 2,000,000 shares of its common stock at a public offering price of $1.00 per share for aggregate gross proceeds of approximately $2.0 million, prior to deducting underwriting discounts and other offering expenses.

Key Points: 
  • CARLSBAD, Calif., March 27, 2024 (GLOBE NEWSWIRE) -- AppTech Payments Corp. (Nasdaq: APCX) (“AppTech” or the “Company”), a pioneering fintech company powering frictionless commerce, today announced the closing of its previously announced underwritten public offering of 2,000,000 shares of its common stock at a public offering price of $1.00 per share for aggregate gross proceeds of approximately $2.0 million, prior to deducting underwriting discounts and other offering expenses.
  • In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 300,000 shares of common stock at the public offering price per share, less the underwriting discounts to cover over-allotments, if any.
  • EF Hutton LLC is acting as the sole book-runner for the offering.
  • The offering was being made only by means of a prospectus supplement and accompanying prospectus.